Inflammatix

A biotechnology company focused on developing a point-of-care instrument platform for diagnosing acute infections and sepsis. Inflammatix leverages the immune system to provide advanced immune response diagnostics, differentiating itself by offering rapid and accurate diagnostic solutions. The primary beneficiaries of Inflammatix's technology are healthcare providers and patients requiring swift and precise infection diagnosis.